Prognostic factors in patients with advanced cholangiocarcinoma: Role of surgery, chemotherapy and body mass index

doi:10.3748/wjg.14.3224

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4308)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

420

HTML

3503

Figures (1-1)

186

Tables (1-4)

199

Sum=4308

May 28, 2008 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. May 28, 2008; 14(20): 3224-3230
Published online May 28, 2008. doi: 10.3748/wjg.14.3224

Open in New Tab Full Size Figure Download Figure

Figure 1 A: Bilirubin level ≥ 10 mg/dL at presentation was associated with decreased survival as compared to lower levels; B: Chemotherapy administration prolonged survival in cholangiocarcinoma patients; C: Surgery added survival benefit in patients with cholangiocarcinoma.

Citation: Farhat MH, Shamseddine AI, Tawil AN, Berjawi G, Sidani C, Shamseddeen W, Barada KA. Prognostic factors in patients with advanced cholangiocarcinoma: Role of surgery, chemotherapy and body mass index. World J Gastroenterol 2008; 14(20): 3224-3230
URL: https://www.wjgnet.com/1007-9327/full/v14/i20/3224.htm
DOI: https://dx.doi.org/10.3748/wjg.14.3224